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Role of Deubiquitinating Enzymes in DNA Repair
Younghoon Kee,a Tony T Huangb
Department of Cell Biology, Microbiology, and Molecular Biology, College of Arts and Sciences, University of South Florida, Tampa, Florida, USAa; Department of
Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York, USAb
Both proteolytic and nonproteolytic functions of ubiquitination are essential regulatory mechanisms for promoting DNA repair
and the DNA damage response in mammalian cells. Deubiquitinating enzymes (DUBs) have emerged as key players in the main-
tenance of genome stability. In this minireview, we discuss the recent findings on human DUBs that participate in genomemain-
tenance, with a focus on the role of DUBs in the modulation of DNA repair and DNA damage signaling.
DEUBIQUITINATING ENZYMES
Safeguarding the genome from genotoxic stress is critical forcell survival and for preventing various human diseases, in-
cluding cancer. DNA repair or DNA damage responses are under
exquisite control and must be accurately and rapidly executed
when genome integrity is challenged. Understanding the molecu-
larmechanisms and regulation of critical DNA repair and damage
response factors in mammalian cells will provide insight into the
pathogenesis of human diseases and aid in the development of
therapeutics. Ubiquitination is a posttranslational modification
event that allows for rapid and dynamic changes in a protein fate
or function. The ubiquitin-proteasome system (UPS) is an essen-
tial posttranslational regulatory mechanism that permeates into
diverse biological processes, including the DNA repair and dam-
age response pathways. While the role of ubiquitin in mediating
controlled degradation/proteolysis of specific proteins is well es-
tablished, nonproteolytic functions of ubiquitination have also
emerged as important players in signaling pathways that often
exist in parallel with the UPS. Deubiquitinating enzymes (DUBs),
responsible for reversing the ubiquitination reaction by removing
covalently attached ubiquitinmolecules from substrates or polyu-
biquitinated chains, have recently exploded onto the ubiquitin
field as key regulators of both the UPS and of the nonproteolytic
functions of ubiquitination. Thus, DUBs exert profound influ-
ence onmany cellular pathways, including one of the best-studied
biological processes involving DNA repair and damage response
in mammalian cells.
There are approximately 95 DUBs encoded by the human ge-
nome, which fall into one of the five subclasses: ubiquitin C-ter-
minal hydrolases (UCHs), ubiquitin-specific proteases (USPs),
Machado-Joseph domain-containing proteins (MJDs), Otubain
domain-containing proteases (OTUs), and JAMM (JAB1/MPN/
Mov34) proteases (1, 2). Ubiquitin has seven internal lysine resi-
dues (Lys6, -11, -27, -29, -33, -48, and -63), each providing sites
for the generation of an isopeptide bond with the carboxy termi-
nus of another ubiquitin to form ubiquitin polymers, otherwise
known as polyubiquitination. Linear ubiquitin chains can also be
generated when the amino-terminal methionine (Met) of ubiqui-
tin (Met1) forms a peptide bond with the carboxy-terminal gly-
cine (Gly) of ubiquitin. As different types of polyubiquitin poly-
mers adopt different conformations (3), it is not surprising that
many DUBs show some degree of specificity toward differentially
linked polyubiquitination, each of which results in a different
physiological outcome. Some DUBs cleave proteasome-targeting
K48 or K11 chains (Ub linkages occur via Lys48 or Lys11 residues
within ubiquitin itself), thus protecting the substrates from deg-
radation, whereas some DUBs preferentially cleave nondegrada-
tive K63-linked chains or monoubiquitinated substrates that usu-
ally serve as altered binding or signaling platforms. While many
USP familymembers are promiscuous (4, 5),mostOTUor JAMM
protease members show inherent specificity, preferring one or a
few defined subsets of linkage types. For example, OTUB1 prefer-
entially cleaves K48-linked chains, and Cezanne cleaves K11-
linked chains (5), while the JAMM proteases, such as AMSH or
BRCC36, preferentially cleave K63-linked substrates (6, 7). Some
OTU members such as OTUB1 and OTUD4 act noncatalytically,
providing examples of how these enzymes have diverse modes of
action.
Consistent with the findings that factors involved in protein
ubiquitination (E1, E2, and E3 enzymes) are integral in modulat-
ing the DNA damage response and repair (8), increasing evidence
demonstrates the critical role of DUBs in these processes as well.
In particular, there has been a plethora of discoveries on DUBs
regulating the DNA damage response and repair of DNA double-
strand breaks (DSBs). In this minireview, we summarize and dis-
cuss the known roles of these DUBs in dictating DSB repair (see
Table 1 and Fig. 1). We will also discuss the DUBs involved in the
repair of other forms ofDNAdamage (see Table 1 and Fig. 2). Due
to the focused nature of this minireview, we will not discuss the
DUBs that regulate the cell cycle checkpoints such as p53 regula-
tion or other chromatin-associated events.
DUBs THAT MODULATE DSB REPAIR SIGNALING
Introduction to ubiquitin-mediated signaling at DSB sites.
DNA double-strand breaks (DSBs) are lethal lesions that must be
repaired before cell division ensues. Homologous recombination
(HR) repair and nonhomologous end joining (NHEJ) repair rep-
resent two major forms of DSB repair mechanisms. HR repair
operates by duplicating genetic information from opposite sister
chromatids and is thus generally considered error-free, whereas
NHEJ repair operates by ligating two broken ends with potential
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mutagenic events arising in the process (9). Mounting evidence
suggests that the appropriate choice betweenHR andNHEJ repair
is crucial in preserving genome integrity. One of the key events in
initiating HR repair is chromatin loading of RAD51, a single-
stranded DNA (ssDNA)-binding protein that facilitates a homol-
ogy search in the sister chromatid to copy the lost genetic materi-
als. ssDNA loading or recruitment of RAD51 to the DSB lesion
requires highly regulated signaling cascades that involve numer-
ous DNA damage response (DDR) factors (10). Among several
posttranslational modifications, ubiquitination plays a key role in
the recruitment processes (Fig. 1). A key initial signaling event in
DSB repair is the phosphorylation of histone variant H2AX by
ATM (ataxia and telangiectasia mutated), which then recruits
downstream factor MDC1 which binds to phosphorylated H2AX
(11, 12). Subsequent phosphorylation of MDC1 by ATM recruits
the twoRINGE3 ubiquitin ligases RNF8 andRNF168 in a sequen-
tial manner (13–18). The current model involves RNF8 recruit-
ment to the sites of chromatin damage by binding of its FHA
(forkhead associated) domain to the phosphorylated MDC1;
RNF8 then induces K63-linked polyubiquitination (polyubiquiti-
FIG 1 DUBs that regulate ubiquitin-dependent signaling, leading to DSB repair. The ubiquitination events upon DSB generation are largely mediated by RNF8
and RNF168 on histones. H1, H2A, H2AX, and H2AZ are known to be ubiquitinated by these ligases. Different DUBs counteract these ubiquitinating events by
differentmechanisms, and some of them appear to act redundantly. The ubiquitination output is read by downstream factors, such as 53BP1, which functionally
antagonize HR factors, such as BRCA1, and regulate the choice of DSB repair pathways. BAP1 and USP16 deubiquitinate H2A-Ub (K119; induced by the
PolycombE3 ligase complex). BAP1 regulatesHR repair, andUSP16 regulatesDSB-induced transcriptional silencing (120, 239). Ubiquitination eventsmediated
by other E3 ligases, such as RNF4, RNF138 (ubiquitinating Ku [240]), and HERC2, or other types of modification (e.g., SUMO or PAR) are not shown for
simplicity. ?a, for the most part, it is not clear whether these DUBs cleave multimonoubiquitinated forms or polyubiquitinated forms on H2A or H2AX. It is not
yet known whether some of these DUBs cleave the K63-linked polyubiquitinated H1. RNF168-induced ubiquitination on H2AZ (241) may also be a substrate.
Some DUBs may also act to cleave the RNF168-induced K27-linked chains on H2A(X). ?b, these DUBs may also target other unknown ubiquitinated proteins
participating inDSB repair signaling. ?c, RNF8 or RNF168may also have other substrates, or it is possible that unanchored polyubiquitin chains nearbyDSB sites
are produced. ?d, both proteolytic and nonproteolytic forms of ubiquitination of CtIP by multiple E3 ligases were reported. The identities of deubiquitinating
enzymes that counteract these processes are unknown.
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nated chains linked through the K63 residue of ubiquitin) on his-
tone H1, which generates a binding site for RNF168 (19). The
initial recruitment of RNF168 requires a MIU (motif interacting
with ubiquitin) ubiquitin binding motif (binds K48- or K63-
linked polyubiquitin [20, 21]), which binds the K63 chain of H1
(19). The RNF168MIUmotif is embedded in surroundingmotifs
that contain specificity determinants termed LR motifs (22). The
recruited RNF168 may further induce K63-linked polyubiquiti-
nation on the K15 residue of core histone H2A, as suggested by an
in vitro reconstitution study (23). The ubiquitin and acidic
patches of H2A may further enhance the recruitment of RNF168
to DSB sites to propagate the signal (19, 23–25). It is possible that
RNF8 or RNF168 generates ubiquitination on yet-to-be identified
targets atDSB sites (24). A proteomic screen found that RNF168 is
also recruited to replication fork-stalled lesions and regulates the
recruitment of the SMC6/6 complex (26). The K63-linked polyu-
biquitination (hereafter referred to as “K63 chains”) by RNF8 and
RNF168 is catalyzed by the UBC13 E2 ubiquitin-conjugating en-
zyme, which is known to form a heterodimer with ubiquitin-con-
jugating enzyme variant (UEV1a) and assembles the nonproteo-
lytic K63 chains (27). Consistent with the role of UBC13 in K63
chain formation, UBC13-knockoutDT40 cells are impaired in the
DSB-induced nuclear focus formation of stable polyubiquitin
conjugates (as detected by the FK2 polyubiquitin-specific anti-
body) as well as downstream DNA repair factors such as RAD51
(13, 28). Consequently, the UBC13-depleted cells display in-
creased genome instability and are hypersensitive to DSB induc-
ers, suggesting HR repair defects (28). In addition to the primary
role of K63 chains, a recent study also showed that noncanonical
K27 chains synthesized on H2A by RNF168 are critical for the
DNA damage response (29). One of the key factors immediately
recruited to the K63 chains generated at DSB sites is RAP80, a
BRCA1-associated factor that contains tandem K63 chain recog-
nizing UIM (ubiquitin-interacting motif) domains (30–33).
RAP80-knockout mice are hypersensitive to ionizing irradiation
and prone to developing lymphomas, and the cells display pro-
longed ubiquitin foci at DSB sites (34). RAP80 serves as a scaffold
to facilitate recruitment of several factors to DSB sites, including
BRCA1. BRCA1, a RINGE3 ligase, performsmultiple functions in
promoting HR repair: it interacts with BRCA2-PALB2 to recruit
RAD51 to chromatin (35, 36), and it promotes DSB end resection
to generate ssDNA, a key HR-initiating event (37). The role of
RAP80 at DSB sites is suggested to sequester BRCA1 from func-
tioning as a HR-promoting factor. The results that RAP80 deple-
tion elevates DSB end resection, RAD51 loading, and HR repair
support this model (38, 39). This mechanism may restrict exces-
sive or aberrant HR repair, which can lead to genomic instability.
Another key function of RAP80 is to recruit BRCC36, aK63 chain-
specific DUB. As we will discuss below, BRCC36 antagonizes
K63 chain formation at DSB sites, thereby regulating NHEJ
repair. How do K63 chains at DSB sites promote NHEJ repair?
A key factor recruited to the DSB sites is 53BP1, which pos-
sesses a TUDOR domain (protein structural motif originally
identified as a region of 50 amino acids found in the Tudor
protein encoded by genes in Drosophila melanogaster that binds
methylated histoneH3 (40), and an ubiquitination-dependent re-
cruitment (UDR)motif, which enables 53BP1 to interact with the
K15-ubiquitinated H2A generated by RNF168 (41). The posi-
tioned 53BP1 facilitates NHEJ repair by multiple mechanisms: by
suppressing BRCA1 recruitment and subsequent DNA end resec-
tion (9, 37, 42, 43), by recruiting anti-DNA end resection factors
RIF1 (44–49) and REV7 (50, 51), and by recruiting Artemis nu-
clease through PTIP (52). Excess RNF168 or 53BP1 increases mu-
tagenic, but not physiological, NHEJ repair (53). The proper reg-
ulation of the K63 chain formation and the subsequent
recruitment of HR or NHEJ factors are critical in dictating DNA
repair and cellular survival in response to DNA-damaging
agents. Determining the pathway choice between HR and
NHEJ in a given cell cycle stage bears significant biological
importance, as activation of an inappropriate repair path-
way(s) can lead to DNA mutation, chromosome translocation,
and overall genome instability.
Increasing evidence demonstrates the critical role of deubiq-
uitinating enzymes in mediating the aforementioned ubiquitin-
mediatedDSB repair signaling. As wewill discuss, much effort has
been put into elucidating how the ubiquitination-dependent
DNA repair signaling is negatively or positively regulated by
DUBs. Below we discuss the current information on the DUBs
that regulate ubiquitin-mediated signaling in the regulation of
DNA repair (Table 1 and Fig. 1).
DUBs thatmodulate the outcomeof double-strand break re-
pair. (i) BRCC36 limitsK63 chains atDSB sites.BRCC36 is aK63
linkage-specific DUB that belongs to the metalloprotease family
containing the JAMM/MPN catalytic domain, unlike the rest of
the other DUB familymembers that are cysteine (Cys)-based pro-
teases with a Cys active site as its catalytic residue (54). A role for
BRCC36 inDSB repairwas initially suggested by localization stud-
ies that found BRCC36 in nuclear foci at DSB sites (or IRIF) and
that the localization was dependent on RAP80 (30). Further stud-
ies found that BRCC36 forms two distinct subcomplexes: (i) a
nuclear “BRCA1-A” complex, which contains BRCC36, BRCA1,
BARD1, RAP80, NBA1/MERIT40, BRE/BRCC45, and CCDC98/
Abraxas (55–60), and (ii) the cytoplasmic BRISC (BRCC36 isopepti-
dase complex) complex, which contains BRCC36, KIAA0157/Abro,
BRE/BRCC45, and MERIT40/NBA1 (61). A key role of the
BRCA1-A complex is to target or sequester BRCA1 to DSB sites to
facilitate DNA repair and to regulate the cell cycle checkpoint
(30–32). In addition, recruiting BRCC36 to the DSB site as part of
the BRCA1-A complex appears to be a crucial event as well.
Knockdown of BRCC36 or overexpression of a catalytically inac-
tive form of BRCC36 increases spontaneous ubiquitin foci at DSB
sites, which suggests that BRCC36 suppresses the ubiquitination.
The study also showed that BRCC36 knockdown restores the
ubiquitin foci in RNF8 knockdown cells (RNF8 is believed to be
the main ligase for K63 chains at DSB sites), suggesting that
BRCC36 antagonizes the RNF8-mediated K63 chain formation
(62). Consistent with the restoration of ubiquitin foci, BRCC36
knockdown can restore 53BP1 focus formation and partially re-
store the ionizing radiation (IR) resistance of RNF8-depleted cells.
Thus, BRCC36 serves as a negative regulator that counteracts the
K63 chain formation at DSB sites to balance DNA repair. Consis-
tent with this model, BRCC36 can suppress RNF168-mediated
chromosome end-to-end fusions via the 53BP1 signaling axis
(63), further underscoring that a physiological function of
BRCC36 is to limit K63 chains during the duration ofDNA repair,
which otherwise would promote unnecessary NHEJ events. Con-
sistent with this finding, the formation of excess K63-linked
chains upon BRCC36 knockdown is associated with increased
DNA end resection, RAD51 loading, HR repair, and IR sensitivity,
further suggesting that stabilized K63 linkages lead to an unpro-
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ductive repair outcome (38, 39). Interestingly, depletion of
BRCC36 leads to elevated recruitment of the anti-HR repair factor
53BP1 to chromatin-associated K63 chains, yet these cells still
experience a hyper-HR phenotype. One possibility is that 53BP1
recruited to the stabilized K63 chains is not sufficient to suppress
HR repair (or enhance NHEJ repair). What is clear is that, based
upon increased chromosomal translocation and IR sensitivity
phenotype, the increased K63 chains in BRCC36-deficient cells
appear to be incapable of supporting DSB repair. Altogether,
BRCC36 appears to play a critical role in suppressing excessive
K63 chains atDSB sites to balance the signals leading to conditions
that are conducive for both HR and NHEJ DNA repair activities.
(ii) POH1 limits excessive NHEJ repair and promotes HR
repair. POH1 (pad one homolog; also called PSMD14, or Rpn11
in Saccharomyces cerevisiae), similar to BRCC36, also possesses a
JAMM/MPN type metalloprotease activity (64, 65). POH1 is an
integral component of the 19S regulatory lid particle of the 26S
proteasome. POH1 was suggested to deubiquitinate proteasomal
substrates prior to feeding them through the 20S cylindrical core
for degradation (64, 65). In addition to disassembling the K48
chains of proteasomal substrates, POH1 can also disassemble
K63-linked polyubiquitinated chains (54). Although the exact
physiological function and substrates of POH1 are unclear, one
purpose of the K63 chain disassembly may be to regulate the DSB
repair signaling; similar to BRCC36, POH1 acts to limit the IR-
induced formation of K63 chains at DSB sites (66, 67). The diam-
eter of the nuclear foci for ubiquitin (antiubiquitin FK2 and K63-
specific antibody) and 53BP1 are larger upon POH1 depletion,
suggesting that the DSB repair signal spreads in the absence of the
DUB (66). As depletion of RNF8 reduces 53BP1 nuclear foci and
NHEJ repair activity, the concomitant reduction of both POH1
and RNF8 can restore the effects of RNF8 partial deficiency. This
suggests that POH1 antagonizes the action of RNF8 in K63 chain
formation and NHEJ repair (66). Importantly, however, POH1
knockdown in healthy cells does not elevate NHEJ repair activity,
again implying that excessive 53BP1 recruitment does not lead to
a more functional NHEJ (66). POH1 knockdown also reduces
RAD51 focus formation andHR repair activity and sensitizes cells
to various DNA-damaging agents via a 53BP1-independent
mechanism (66). Although it is not clear howPOH1promotesHR
repair, a three-dimensional (3D) imaging study showed that
POH1 cooperates with BRCA1 to eliminate 53BP1 from a nuclear
focus core and to allow repositioning of replication protein A
(RPA) (replication protein A binds to single-stranded DNA) in
the focus core, potentially indicating an HR-initiating event (67).
Consistent with POH1’s role in DNA end resection, POH1-de-
pleted cells lack RPA phosphorylation (a marker for the initiating
events of DNA end resection for HR repair). Thus, POH1 appears
to act as a decision maker between HR and NHEJ repair by mod-
ulating the DNA end resection events. Altogether, these results
suggest that POH1 antagonizes NHEJ activity by limiting the
abundance of K63 chains, and perhaps repositioning 53BP1 at the
DSB sites, to promote HR repair.Why and how is POH1 localized
to such sites to regulate DSB repair signaling? Insight could po-
tentially be derived from a structural study of yeast Rpn11 (yeast
homolog for POH1) (68). First, the study found that Rpn11 is an
unstable protein without its neighboring subunit Rpn8 and that
the Rpn8-Rpn11 heterodimer is catalytically active in vitro. This
suggests that POH1may also need to be in complex with its neigh-
boring 19S subunits for activity and that an intact 19S lid complex
may be localized to DSB sites as whole, along with POH1. Indeed,
PSMC5, a 19S subunit, is observed in the DSB sites (66), and
proteasomal subunits have been found to localize to DSB sites
using chromatin immunoprecipitation (ChIP) studies in yeast
(69). The mechanism by which the 19S lid complex is recruited to
the DSB sites is unknown. The N terminus of POH1 has been
shown to interact with a transcription factor, Mitf, to regulate its
activity (70), which provides an example pf how POH1 can be
localized to specific sites in chromatin. Second, the study found
that the purified Rpn11-Rpn8 complex lacks specificity toward
different ubiquitin chain types tested, which is supported by the
fact that Rpn11, unlike otherMPN familyDUBs, lacks a conserved
binding surface for the Ile44 residue on ubiquitin that helps to
properly orient the ubiquitin polymer for linkage-specific cleav-
age. This suggests that Rpn11 is not likely to cleave internal link-
ages within the K63 chains and that it may instead cleave the first
“proximal” ubiquitin attached to substrates (71). This feature of
cleaving polyubiquitin chains en bloc off various proteasomal sub-
strates is consistent with a previous study on Rpn11 (65). Perhaps
the ability of Rpn11 to cleave a bulk polyubiquitin chain at the
proteasome lid suggests that it can perform similarly at the DSB
sites; it is possible that POH1 also cleaves the ubiquitin chains en
bloc off histones or other unknown substrates at DSB sites, which
may rapidly neutralize ongoing DSB repair signaling. This activity
may generate free unanchored K63 chains that can be disassem-
bled by otherK63 linkage-specificDUBs to completely turn off the
signaling pathways. UBP14, a yeast homolog of USP5, is largely
responsible for disassembling unanchored free polyubiquitin
chains in cells (72). Interestingly, USP5 is localized to DSB sites,
and the polyubiquitin chains at DSB sites are sustained longer in
USP5-depleted cells (73). USP5 may indeed disassemble any un-
anchored K63 chains at DSB sites, as a structural study showed
that a ZnF-UBP (zinc finger ubiquitin binding domain) domain
of USP5 recognizes the C-terminal “Gly-Gly” motif of unan-
chored ubiquitin, rather than the Ile44 residue of ubiquitin which
most DUBs recognize (74). Indeed, mutation in the domain that
recognizes the free C terminus of ubiquitin inactivated the polyu-
biquitin-disassembling activity of USP5. Thus, it is possible that
sequential activities of POH1 and USP5 collaborate to turn off
DSB repair signaling. The possible role of USP5 in the DSB repair
is also supported by a RNA interference (RNAi) screen that found
USP5 localized at DSB sites and that USP5-depleted cells exhibit
repair defects (75).
(iii) RNAi screen identifies that OTUB2 antagonizes RNF8-
mediated K63 linkages. A small interfering RNA (siRNA) screen
identified that the K63-ubiquitin conjugates at DSB sites are fur-
ther antagonized by OTUB2, a member of the OTU family of
DUBs (76). OTUB2 depletion spontaneously increases focus for-
mation of ubiquitin, 53BP1, RAP80, and RNF168 at DSB sites.
While overexpressing OTUB2 eliminated RAP80, RNF168, and
ubiquitin foci, OTUB2 did not affect the focus formation of their
upstream factors (MDC1 or RNF8); this suggests that OTUB2
inhibits the RNF8 activity or certain downstream functions of
RNF8 that are required for RNF168 recruitment. OTUB2 can
cleave UBC13/MMS2-induced free K63-linked polyubiquitin
conjugates in vitro, supporting the fact that OTUB2 acts to antag-
onize the K63 chains at DSB sites. PurifiedOTUB2 indeed shows a
preference for cleaving the K63-linked diubiquitin substrates,
with some activity toward K48 and K11 linkages (5) (although
OTUB2 can cleave both K48- and K63-linked tetraubiquitin sub-
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strates as well [77]). As Mattiroli et al. suggested, RNF8/UBC13-
mediated K63 chain formation precedes the RNF168 recruitment
to nucleosomes (24), and OTUB2 may act to suppress K63 chain
formation to inhibit RNF168 recruitment. Consistent with the
notion that RAP80 and 53BP1 suppress HR-initiating events such
as DNA end resection and RPA foci, HR repair activity is de-
creased uponOTUB2 depletion. Coknockdown of 53BP1 rescued
RAD51 and RPA focus formation in OTUB2 knockdown cells,
which suggested that increased 53BP1 is responsible for the sup-
pression of end resection and HR repair. Surprisingly, overex-
pressing OTUB2 did not reduce the level of multi- or polyubiq-
uitinatedH2A (OTUB1 [discussed below] overexpression had the
opposite effect). This raises the possibility that there is yet-to-be
appreciated complexity among the H2A-ubiquitin types that dif-
ferentially recruit downstream repair factors. Perhaps related to
this point is that BRCC36 andOTUB2, while both antagonize K63
chain formation at DSB sites, lead to very different outcomes:
BRCC36 depletion elevates HR repair, whereas OTUB2 depletion
suppress HR repair. It may be that recruitment and formation of
HR-suppressive RNF168-RAP80-53BP1 components are differ-
ently configured depending on the differential actions of DUBs at
DSB sites. Alternatively, it is possible that BRCC36 or OTUB2
have additional functions in regulating DNA repair other than
modulating the K63 chains. The Kato et al. study (76) found that
OTUB2 deubiquitinates LSMBT1, an event which may promote
the chromatin loading of 53BP1 recruitment.
(iv) USP3 deubiquitinates H2AX and suppresses genome in-
stability. USP3 is a homolog of Saccharomyces cerevisiae Ubp8,
which deubiquitinates H2B (78, 79). Consistent with its role in
chromatin modification, USP3 is localized to the nucleus and
chromatin-enriched fractions (80). Ectopic expression of USP3,
not the catalytically inactivemutant (active site Cysmutant), leads
to a reduction in mono- and diubiquitinated H2A and H2B,
whereas knockdown of USP3 increases the ubiquitinated histones
(80). The persistent ubiquitination induced by USP3 knockdown
is associated with persistent H2A-Ub and H2AX foci. As the au-
thors suggested, this may be due to a defect in attenuation of DDR
that is dependent on histone ubiquitination or other functions of
USP3 thatmay be related toDNA replication or damage response.
More recent work further demonstrated thatUSP3 deubiquiti-
nates H2AX and H2A (81). Knockdown of USP3 increases stain-
ing intensity of ubiquitin foci, and overexpressing wild-typeUSP3
but not the catalytic inactive mutant suppresses UV-induced
monoubiquitination of H2A/H2AX and focus formation of
BRCA1 and 53BP1. The reduction of H2A-Ub was observed with
the FLAG-H2A K118-119R mutant but not with the FLAG-H2A
K13-15R mutant, suggesting that USP3 cleaves ubiquitin conju-
gated to K13-15 residues. Therefore, it was suggested that USP3
counteracts the RNF168-mediated K13-15 ubiquitination on
H2A. It is possible thatUSP3 also regulatesH2B-ubiquitin, similar
to its yeast homolog Ubp8, which is based upon the reduction of
H2B-ubiquitin upon USP3 overexpression observed in another
study (82). The in vivo significance of USP3 function was demon-
strated by studies withmice deficient inUsp3 (usp3/ [83]). The
cells from usp3 knockout mice display an increased level of H2A-
Ub, and spontaneous focus formation of Ub chains (FK2), 53BP1,
and -H2AX, suggesting that the DSB signaling is increased and
genome integrity is compromised. USP3 depletion causes defects
in hematopoietic stem cell homeostasis, and interestingly, the
usp3 knockout mice spontaneously developed tumors, which can
be attributed to impaired genome integrity and underscores the
importance of ubiquitin-mediated signaling in DNA repair.
(v) Overexpression screening studies identify various DUBs
as inhibitors of the DSB signaling. Several studies used human
DUB overexpression libraries to identify DUBs that regulate the
ubiquitin and DNA damage signaling, as we discuss in this sub-
section.
In a study that used H2AXmonoubiquitinationWestern blot-
ting as a readout, Dub3 (also known as USP17L2) was found as a
major hit (84). Overexpression of Dub3 but not its catalytic inac-
tive mutant reduces the monoubiquitinated forms of H2AX and
H2A. The study convincingly showed that Dub3 physically binds
to H2AX and that purified Dub3 can deubiquitinate the monou-
biquitinated H2AX in vitro, suggesting that the overexpression
effect is direct. Overexpressing Dub3 abrogates the damage-in-
duced focus formation of 53BP1, BRCA1, and RNF168 but not
H2AX or MDC1, suggesting that the Dub3-induced deubiquiti-
nation of H2AX influences canonical DSB signaling. This result is
consistent with a finding that 53BP1 is a direct reader of H2A-
monoubiquitin (41). Excessive deubiquitination ofH2A orH2AX
by overexpressing Dub3 resulted in sustained activation of H2AX
and MDC1, suggesting that overall DSB signaling is impaired
upon Dub3 overexpression.
In a study that used 53BP1 chromatin foci as a screening read-
out, USP44 was identified as an antagonist of RNF168-mediated
Ub conjugates atDSB sites (82).Overexpression ofUSP44 inhibits
focus formation of IR-induced Ub conjugates (FK2), RNF168,
RAP80, and 53BP1 at DSB sites. Similar to USP3, USP44 overex-
pression effectively reduced mono- and multiubiquitinated H2A
(and H2B-Ub to a lesser degree). USP44 is recruited to the IR-
induced DSB sites, a process dependent on RNF8 and RNF168,
suggesting that USP44 recruitment depends on Ub conjugate for-
mation and that USP44 antagonizes IR- and RNF168-induced
H2A ubiquitination; whether USP44 specifically cleaves
H2AK119-Ub or K13/K15-Ub is not known. The study found
only a mild increase in the Ub conjugates and 53BP1 foci upon
individual knockdown of USP3, USP44, or OTUB1. This result
suggests that these DUBs function redundantly or synergistically
and that there is not a single DUB that is solely responsible for
removing the bulk ubiquitin conjugates at DSB sites. It was also
noted that simultaneous knockdown of these DUBs did not result
in further increase in focus formation (82). The reduction in ubiq-
uitinated H2B upon overexpressing USP44 in the study is consis-
tent with another study that links USP44 in deubiquitinating H2B
and stem cell differentiation (85).
USP44 also plays an important role during cell division. USP44
inhibits premature activation of APC/CE3 ligase by stabilizing the
APC-inhibitory MAD2-CDC20 complex (86) and regulates
proper separation and positioning of centrosomes—failure of
which can lead tomissegregation of sister chromatids during ana-
phase (87). Indeed,mouse embryo fibroblast (MEF) cells from the
USP44 knockoutmice display aneuploidy, and themice are prone
to tumor development (87), and overexpressing USP44 also in-
duces chromosome segregation errors and aneuploidy (88). Inter-
estingly, it was found that USP44 is localized to centrosomes via
specific interaction with centrin and that wild-type USP44, but
not the centrosome localization-defective pointmutant or the cat-
alytically inactive mutant, can rescue the chromosome segrega-
tion defects, demonstrating that the centrosome pool of USP44 is
essential in preventing chromosome missegregation (87). Al-
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though the increased aneuploidy can be a significant factor in
tumor development, aneuploidy alone may not play a causative
role in tumor development (89). In light of the connections be-
tween defective DNA repair and mitotic defects, it is possible that
the aberrant ubiquitin signaling in DSB repair contributes to the
mitotic defects and tumor development upon USP44 ablation.
Another study also used 53BP1 focus formation as a screening
readout, and this study found USP26 and USP37 as major antag-
onists of the IR-induced 53BP1 foci (90). This study found Dub3
and USP44 in the screen, consistent with the other screenings
described above. The study showed that overexpressing wild-type
USP26 and USP37 but not catalytic inactive mutants of USP26
and USP37 suppressed the 53BP1 and ubiquitin foci at DSB le-
sions. Overexpression of USP26 significantly suppressed the
RNF168-induced H2A ubiquitination, but USP37 did not have
much effect. Localization of both USP26 and USP37 at DSB sites
was observed, suggesting that the effects are direct. The increased
ubiquitin (FK2) and 53BP1 foci upon USP26 or USP37 deple-
tion are associated with downregulation of the HR repair; dam-
age-induced foci of HR factors RAD51, BRCA1, and PALB2 are
decreased. Interestingly, codepletion of RAP80 rescued the re-
duced HR foci. These results suggest that perhaps the role of
RNF168-mediated ubiquitination is to control the abundance
between the HR-promoting BRCA1-RAP80-PALB2 complex
and the HR-suppressing “BRCA1-A complex” BRCA1-RAP80-
MERIT40 (NBA1)-Abraxas (CCDC98)-BRCC36; in general,
RNF168 would promote the recruitment of the latter complex.
This provides another example of how the intricate balance of
ubiquitination at DSB sites is important for a proper choice of
DSB repair.
In another screen that used a DUB overexpression library,
USP11 was shown to deubiquitinate H2AX (91). This study used
ubiquitinated H2AX (induced by overexpressing RNF8) coupled
with overexpressing 72 DUBs. The primary hits identified in this
study included USP26, OTUB1, DUB3, in addition to USP11,
validating the results from other screenings. Knockdown of
USP11 increased the H2AX-Ub forms, which is consistent with
the overexpression results. USP11 knockdown also leads to in-
creases in 53BP1 and ubiquitin (FK2) formation at DSB sites and
to cellular sensitization to IR, suggesting that deregulation of
H2AX ubiquitination leads to improper DSB signaling and repair.
USP11 physically associates with H2AX, further suggesting that
H2AX is a direct substrate of USP11. Consistent with this finding,
USP11 is one of the hits found to be localized atDSB sites, and cells
exhibit repair defects when USP11 is depleted (75). Also consis-
tently, earlier studies found thatUSP11 knockdown sensitizes cells
to PARP inhibition (found in a RNAi screen) and IR (92, 93),
suggesting that USP11 regulates the DSB repair. One study
showed that USP11 interacts with and deubiquitinates BRCA2,
possibly to regulate the proteasomal degradation of BRCA2 (92).
USP11 may further regulate the DSB repair by a different mecha-
nism. USP11 is shown to associate with RNF4, an E3 ligase that
modulates SUMO-modified targets, and counteracts the RNF4-
induced SUMO-ubiquitin hybrid chains (94). Since RNF4 is re-
cruited to DSB sites and is required for DSB repair (95–99), it is
possible thatUSP11 antagonizes some of the RNF4-directed ubiq-
uitination at DSB sites.
(vi) Inhibition ofUBC13E2-conjugating enzymebyOTUB1.
OTUB1 is an OTU family deubiquitinating enzyme that has high
specificity towardK48-linked chains (5). OTUB1was identified as
a negative regulator of RNF168-mediated Ub conjugate forma-
tion in a siRNA screen; knockdown of OTUB1 leads to spontane-
ous and persistent Ub conjugates and 53BP1 foci (100). Intrigu-
ingly, overexpressing a catalytically inactive mutant of OTUB1
inhibited 53BP1 focus formation as efficiently as overexpressing
thewild-type enzyme,which suggested that the catalytic activity of
OTUB1 is not required (although thewholeOTUdomainmust be
present), and together with the fact that OTUB1 is known to be
specific for K48 linkages, it was concluded that OTUB1 may not
directly deubiquitinate the K63 linkages at DSB sites. Further
analysis revealed that OTUB1 physically interacts with the
UBE2D/E subfamily of E2-conjugating enzymes, including
UBC13which assembles theK63 chains atDSB sites. Interestingly,
OTUB1 binds preferentially toUBC13 that are chargedwith ubiq-
uitin through the OTUB1’s unique N-terminal extension that
bears a ubiquitin binding motif (100). The interaction leads to
disruption of RNF168/UBC13-mediated polyubiquitination
through amechanism independent of deubiquitinating activity. A
structural study revealed that the binding of the N terminus of
OTUB1 to theUb-chargedUBC13 is allosterically regulated by the
binding of a free ubiquitin to a second site in OTUB1; it triggers
conformational changes in the ubiquitin-binding helix in the N
terminus, thereby enhancing affinity to the E2-charged ubiquitin.
The interaction ultimately disrupts the ability of the E2-charged
ubiquitin thioester bond to be attacked by an acceptor ubiquitin
(on the substrate), which can explain the inhibition of K63 chain
synthesis. Consistent with the model, OTUB1 inhibits UBC13-
dependent diubiquitin synthesis but not the initial monoubiquiti-
nation (100). It was suggested that the configuration of the E2-
charged ubiquitin and the free ubiquitin moieties at the OTUB1
catalytic site mimic cleaved K48 linkages, whichmay be a basis for
OTUB1 inhibiting the E2 enzyme (101). By inhibitingUBC13 and
K63 chain synthesis, OTUB1 regulates DNA repair; overexpres-
sion of OTUB1 suppresses HR repair activity, and interestingly,
knockdown of OTUB1 leads to nearly complete restoration of the
HR repair defect that is caused by ATM inhibition (100). OTUB1
is also capable of inhibiting other E2 enzyme family members
UBE2D andUBE2E, suggesting that it also exerts other physiolog-
ical functions outside the DNA repair signaling through similar
mechanisms (100, 101).
OTUB1 is also subject to reciprocal regulation by anE2 enzyme
UBCH5B. It was shown that UBCH5B directly binds to and stabi-
lize the N-terminal ubiquitin-binding helix of OTUB1, thus in-
creasing the affinity to a proximal ubiquitin moiety and stimulat-
ing the di-K48-ubiquitin chain cleavage activity (102). It is
possible that the OTUB1-UBC13 interaction may be dynamically
regulated during the DNA damage response.
(vii) StabilizationofRNF168E3enzymebyUSP34andUSP7.
Two USPs have been reported to directly associate with RNF168
and prevent it from undergoing proteasome-mediated destruc-
tion (UPS pathway). RNF168 is the aforementioned E3 ubiquitin
ligase that induces mono- and polyubiquitination of H2A/H2AX.
USP7 (103) and USP34 (104) directly bind, deubiquitinate, and
stabilize RNF168. Consistent with the role of RNF168 in DNA
damage-induced formation of monoubiquitin and K63-linked
polyubiquitin conjugates, depletion of USP7 or USP34 reduces
the level of H2A-ubiquitin and overall Ub conjugates at DSB sites
(104). Thus, USP7 and USP34 promote Ub conjugate formation
at DSB sites, which in turn promotes recruitment of downstream
DDR mediators 53BP1 and BRCA1, and confer resistance to
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DNA-damaging agents (103, 104). Maintaining the balance of
RNF168 abundance atDSBsmay have an important consequence,
as failure to do so results in improper spreading of ubiquitin con-
jugates to undamaged chromatin (105). It is not knownhowUSP7
and USP34 are recruited to the damaged sites or whether they
form stable complexes with RNF168; however, USP34 forms IR-
inducible foci at DSBs in a manner that is dependent on RNF168
andUBC13. This suggests that USP34 recruitmentmay be depen-
dent on the local ubiquitinated proteins or direct binding to
RNF168 (104). In yeast, Rsp5 HECT E3 ligase forms a stable com-
plex with Ubp2 deubiquitinating enzyme to promote assembly
and disassembly of K63-linked polyubiquitin chains on their sub-
strates as well as on Rsp5 itself (106–108). Similarly, it is possible
that USP7 or USP34 is recruited to the damaged sites by forming
stable complexes with RNF168 to support the stability of RNF168.
It is not known whether USP7 or USP34 regulates RNF168 in
different contexts or whether they serve redundant roles. Interest-
ingly, RNF168 is itself polyubiquitinated and destabilized upon IR
treatment, which is reversed by USP34, suggesting that USP34
specifically stabilizes RNF168 when DNA becomes damaged
(104). It is not clear by what mechanism RNF168 is induced for
polyubiquitination and degradation, although two HECT E3
ubiquitin ligasesUBR5 andTRIP12 have been shown tonegatively
regulate the abundance and spreading of RNF168 foci at DSB sites
(105). Whether the two HECT E3 enzymes directly catalyze
polyubiquitination of RNF168 or whether RNF168 self-catalyzes
by coupling with K48 linkage-specific E2 enzymes is unknown.
Overall, these studies indicate that maintaining the balance of
RNF168 abundance at DSBs is important in promoting DSB re-
pair signaling. USP7 is also shown to stabilize TIP60 histone
acetyltransferase (109), which acetylates ATM and promotes
DNA damage signaling (110); it also promotes the stability of
BMI1 (103), a component of the Polycomb-repressive complex
(PRC1) that induces ubiquitination of H2A at the K119 residue
that induces transcriptional repression (111). BMI1 localizes to
IR-induced foci and promotes DSB repair signaling (112–114).
Thus, USP7 appears to exert multiple functions at chromatin to
promote DSB repair signaling and perhaps organize damage-in-
ducible local transcriptional repression.
(viii) BAP1 promotes HR repair. BAP1 (BRCA1-associated
protein 1) is a nuclear deubiquitinating enzyme with a ubiquitin
carboxy-terminal hydrolase (UCH) domain. BAP1 was initially
reported as a tumor suppressor that suppresses breast cancer
growth in a BRCA1-dependent manner (115). Cancer-associated
BAP1 mutants are linked to deficiency in deubiquitinating activ-
ity, and the catalytic mutant cannot suppress tumor growth in
mice (116). Studies found that BAP1 is a regulator of DSB repair,
in particular by promoting HR repair (117, 118). BAP1 is rapidly
recruited to DSB sites, and BAP1 depletion leads to reduced
BRCA1, RAD51, and RPA foci. Consequently, BAP1 depletion
leads to reduced HR repair and sensitivity to IR. Overexpressing
BAP1 reduces ubiquitinated forms of H2A and H2AX, while de-
pletion increases them, suggesting that BAP1 is a DUB for the
ubiquitinated H2A(X) (117). The ubiquitinated site for H2A(X)
was suggested to be the K119 residue, and this is consistent with
the fact that a BAP1 homolog inDrosophila, Calypso, is associated
with PRC1 and regulates H2AK119 ubiquitination (119). There-
fore, BAP1 may engage in a dynamic regulation of this modifica-
tion. Whether the role of BAP1 is redundant or cooperative with
USP16, another DUB that deubiquitinates H2AK119 (120), is un-
known.
(ix) UCHL5 andUSP4 regulate theHR repair bymodulating
DSB end resection. A crucial regulatory event during the DSB
repair is the generation of a stretch of single-stranded DNA
(ssDNA) at the DSB sites, or so-called DSB end resection. The
ssDNA generated at the DSB lesions is subsequently coated by
heterotrimeric RPA complex. The coated RPA performs many
important functions.
Studies with yeast showed that the coated RPAs prevent the
activation of MMEJ (microhomology-mediated end joining), an
error-prone form of NHEJ (121), and the formation of DNA sec-
ondary structures that induce genome instability (122). RPAs also
recruit the ATR-ATRIP kinase complex (123) and activate DNA
damage checkpoint and cell cycle arrest (123–125). As a prochoice
mechanism for HR repair, RPA-coated ssDNA recruits RAD51,
which initiates strand invasion, homology search, and subsequent
HR repair (126, 127).
The DSB end resection during mitotic DSB repair is mediated
by a concerted action of several nucleases. Currentmodels suggest
that theMRN (MRE11-RAD50-NBS1) complex collaborates with
CtIP endonuclease (Sae2 in budding yeast, Ctp1 in fission yeast) to
initially trim the DSB ends (128–131). Recruitment of the MRN
complex and the end resection require the MCM8-MCM9 com-
plex (132). Subsequent reactions requiring the nucleases Exo1,
Sgs1 (BLM in human) and Dna2 function redundantly or collab-
oratively to induce extensive ssDNA, onto which RPA binds (131,
133–135). CtIP knockout (KO)mice is embryonic lethal, andCtIP
is essential for suppressing genome aberration (136, 137). CtIP/
Sae2 is also highly regulated by posttranslational modifications,
including phosphorylation (138–141), acetylation (142, 143),
ubiquitination (both proteolytic and nonproteolytic) (144–147),
and deregulation of these processes lead to DSB repair deficiency,
evidence that the DSB end resection is subject to a dynamic regu-
lation.
Studies identified that two DUBs, UCHL5 and USP4, regulate
DSB end resection. Two studies found that DNA end resection is
positively regulated by USP4 in response to DNA damage (148,
149). Both studies found that USP4 interacts with the DNA end
resection factor CtIP, as well as with the MRN complex, through
two distinct regions within USP4. USP4 knockdown reduced the
recruitment of CtIP, RPA (reduced RPA2 S4-S8 phosphoryla-
tion), and RAD51 to sites of DSBs, suggestive of impaired DNA
end resection. Unexpectedly, both studies found that CtIP is not a
direct ubiquitin-modified substrate of USP4; rather, USP4 is itself
ubiquitinated, and its deubiquitination is dependent on its own
catalytic activity. These studies found that the catalytically inactive
USP4mutant cannot efficiently interactwithCtIP andMRNcom-
ponents compared to the wild-type form, implying that the in-
creased ubiquitination of USP4 interferes with these interactions.
Expression of the catalyticmutant forms cannot fully supportHR,
underscoring the significance of the autodeubiquitination activity
of USP4 to promote proper CtIP interaction and localization to
enable DNA end resection and HR activity. Interestingly, the Wi-
jnhoven et al. study found that the ability of USP4 to undergo
autodeubiquitination to mediate protein-protein interactions
may be shared by other USPs, such as the structurally related
USP11 and USP15 (149). As USP15 and USP4 may have arisen
from genome duplication (150), USP15 may also participate in
DSB repair. Additionally, it was purported that the zinc-coordi-
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nating Cys residues on USP4, not lysines, are the targets of ubiq-
uitin conjugation. It is unclear whether ubiquitination of Cys res-
idues is a prevalent mode of regulation of Cys-based DUBs in
general. Although the ubiquitin linkage type targeted by USP4 for
autodeubiquitination remains elusive, USP4 has been shown to
deubiquitinate K63-linked proteins and regulate the spliceosome
assembly (151), providing another example that USP4 functions
to modulate protein interactions.
Nishi et al. (75) used a combination of green fluorescent pro-
tein (GFP) localization and RNAi screenings of the human DUBs
to identify that UCHL5 (also called UCH37) is a regulator of DSB
end resection. UCHL5 is localized to DSB lesions, and UCHL5
knockdown leads to increased DSBs and cellular sensitization to
DSB-inducing drugs. Further analysis showed that UCHL5
knockdown selectively impaired HR repair but not NHEJ and
specifically that DSB end resection was impaired upon UCHL5
knockdown. The fact that UCHL5 is a component of both the
proteasome lid as well as the INO80 chromatin-remodeling com-
plex prompted the authors to sort out which macrocomplex is
involved in the end resection regulation; they found that rather
than collaborating with the proteasome, UCHL5 suppresses ubiq-
uitination and proteasomal degradation of NFRKB (nuclear fac-
tor related to kB-binding protein), a factor known to mediate the
association of UCHL5 with INO80 (152). Indeed, INO80 is
known to directly associate withDSB ends and is required forDSB
end resection and overall DSB repair (153, 154).
DUBs THAT REGULATE DNA REPLICATION-ASSOCIATED
DNA DAMAGE RESPONSE
USP1 deubiquitinates FANCD2 and FANCI to regulate DNA
ICL repair.DNA interstrand cross-links (ICLs) are complexDNA
lesions that can be generated by various endogenous and exoge-
nous sources that include aldehyde and platinum-based drugs
such as cisplatin or mitomycin C. ICLs can be lethal if unrepaired,
leading to blockade of DNA replication and transcription. In ver-
tebrates, ICL repair is largely coupled to DNA replication due to
the activation of a dedicated coordinator of replication-coupled
ICL repair called the Fanconi anemia (FA) pathway. The FA path-
way facilitates ICL repair by coordinating multiple types of repair
pathways, including nucleotide excision repair (NER), homolo-
gous recombination (HR), and translesion synthesis (TLS) (155).
One of the key steps that leads to FA pathway activation is the
monoubiquitination of FANCD2 and FANCI proteins on Lys561
and Lys523, respectively (human sequence), which is mediated by
the multisubunit FA core E3 ligase complex (156–158) (Fig. 2).
Monoubiquitination of FANCD2 and FANCI peaks during S
phase of the cell cycle, which is consistent with the timing of HR
and TLS events in the cell. The monoubiquitinated FANCD2 per-
forms multiple functions in coordinating the downstream repair
activities by recruiting the following: (i) FAN1 and XPF-ERCC
nucleases to facilitate the incision process and unhooking of the
cross-linked DNA segment (159–164); (ii) TLS polymerase to fa-
cilitate replicative bypass of the unhooked ICL lesion (165); and
(iii) exonuclease CtIP to induce 3=-to-5= resection of DSB DNA
ends to generate ssDNA to channel the broken DNA ends to HR-
mediated repair (166–168). Although the requirement for
monoubiquitinated FANCD2 is well established in replication-
coupled ICL repair, the receptor that interacts specifically with the
monoubiquitinated form remains controversial and has yet to be
identified. The role of FANCImonoubiquitination is less well un-
derstood, but it is minimally required for the efficient monoubiq-
uitination of FANCD2 and is thought to stabilize the FANCD2-
FANCI heterodimer (157). There are also monoubiquitination-
dependent and -independent functions of FANCD2 and FANCI
in protection against general DNA replication stress (169, 170)
that will not be discussed in this minireview due to space con-
straints.
USP1 was initially identified as a regulator of FANCD2
monoubiquitination in a DUB family siRNA genetic screen,
which showed that depletion of USP1 increases spontaneous
monoubiquitination of FANCD2 (171). A later study found that
USP1 is also required for deubiquitination of FANCI (157). In-
triguingly, the USP1 knockout is associated with defects in DNA
repair and increased cellular sensitivity to DNA ICL-inducing
agents inmice andDT40 cells, suggesting that deubiquitination of
FANCD2-FANCI is also an essential event in DNA ICL repair
(172, 173). How can this phenomenon be interpreted? It is spec-
ulated that perhaps FANCD2 (and FANCI) monoubiquitination
is dynamically regulated by USP1 during S phase, undergoing
multiple rounds of reversible monoubiquitination events. Dis-
ruption of this dynamic regulation in USP1-depleted cells led to
reduced overall FANCD2 recruitment to the damaged sites (local-
ization of FANCD2 and FANCI nuclear foci was initially thought
to be monoubiquitination dependent). Thus, perhaps a role for
USP1 is to regulate the turnover of FANCD2-FANCI monoubiq-
uitination at the damaged sites to facilitate multiple rounds of
repair during S phase, rather than for USP1 to act only once just as
cells exit S phase for repair recovery. The fact that theUSP1 level is
higher while FANCD2-FANCI monoubiquitination is also ele-
vated (S-G2 phases) further supports the idea that USP1 activity is
needed for the FANCD2-mediated ICL repair (174).
How does USP1 directly deubiquitinate FANCD2 and FANCI?
The ability of USP1 to gain access to FANCD2-FANCI proteins
may be mediated through its WD40 repeat-containing catalytic
cofactor, UAF1 (WDR48). UAF1 was identified as a stoichiomet-
ric binding partner of USP1 (175). Similar to USP1, depletion or
knockout of UAF1 also results in hypermonoubiquitinated
FANCD2 and FANCI (176, 177), suggesting that UAF1 is a posi-
tive regulator of USP1. Importantly, UAF1 binding to purified
USP1 increases the catalytic turnover (kcat) but does not increase
the affinity of USP1 for the substrate (Km) ubiquitin-7-amido-4-
methylcoumarin (Ub-AMC) in an intrinsic DUB activity mea-
surement (177). In addition to its role as a catalytic cofactor,UAF1
may also recognize and bind directly to USP1 substrates, serving
as a bridge or adaptor for USP1 to recognize its ubiquitinated
substrates. The carboxy terminus of UAF1 harbors SUMO-like
sequences (termed the SUMO-like domain [SLD]), which can be
recognized by a SUMO-interactingmotif (SIM) present in FANCI
(178). Thus, USP1 may be recruited to the FANCD2 and FANCI
(inhibitor of DNA binding [ID]) complex through the SUMO-
like delivery system between UAF1 and FANCI proteins. How-
ever, the physiological relevance of this interaction has yet to be
formally demonstrated. Adding to this piece of the puzzle, UAF1
also serves as a catalytic cofactor and binding partner for two other
DUBs, USP12 and USP46 (175). To date, these DUBs do not ap-
pear to function in the FA pathway. It is unclear whether these
DUBs can also be recruited to FANCI via the SUMO-like delivery
system on UAF1.
USP1 deubiquitinates PCNA to regulate translesion synthe-
sis (TLS) for DNA damage tolerance.USP1 also plays an impor-
Minireview
532 mcb.asm.org February 2016 Volume 36 Number 4Molecular and Cellular Biology
 o
n
 July 6, 2018 by Univ of South Florida
http://m
cb.asm
.org/
D
ow
nloaded from
 
tant role in regulating TLS events in cells via the deubiquitination
of PCNA (proliferating cell nuclear antigen). PCNA normally
functions as a DNA replicative polymerase sliding clamp that en-
sures the replicative DNA polymerase’s processivity during DNA
synthesis. It also plays a key role in mediating DNA damage toler-
ance through the recruitment of the more error-prone Y-family
TLS polymerases (Pols), such as Pol eta, kappa, iota, and Rev1, to
allow for replicative bypass of DNA lesions during replication,
otherwise known as postreplication repair. PCNA is known to be
monoubiquitinated on Lys164 (conserved from yeast to mam-
mals) by various DNA-damaging agents (hydroxyurea [HU],
aphidicolin, UV, and MMS) that cause the slowing or stalling of
replication forks. Interestingly, USP1 also utilizes the SUMO-like
delivery system to recognizemonoubiquitinated PCNA, similar to
FANCD2. Instead of recognizing the SIMs on FANCI, the SLD
sequence onUAF1 recognizes the SIM on ELG1, a PCNA-binding
RFC-like protein which serves as a substrate adaptor for PCNA
deubiquitination by the USP1-UAF1 complex (178, 179). While
Y-family DNA Pol eta, kappa, and iota are recruited to PCNA
through a weak PCNA-interacting protein (PIP) box, Rev1 uti-
lizes its BRCT domain and/or its PAD domain for localization. All
Y-family TLS Pols have one or two ubiquitin-binding domains
(UBD), which adds to their affinity formonoubiquitinated PCNA
at the sites of stalled forks. Anothermechanism that facilitates TLS
Pol localization to damaged DNA is through the direct recruit-
ment to Rev1, which can serve as a scaffolding protein for the TLS
Pols (180). Conversely, it has been postulated that the deubiquiti-
nation of PCNA by USP1 facilitates the removal of TLS Pols from
the replication fork in exchange for the replicative Pols (Epsilon
and Delta) (181).
Similar to FANCD2, elevated levels of PCNAmonoubiquitina-
tion (caused by USP1 depletion in unperturbed cycling cells) can
be disruptive to its normal error-free DNA replication kinetics, as
excessive and/or aberrant recruitment of TLS Pols, such as Pol
kappa, to the replication fork leads to reduced fork speeds and is a
contributing factor to genomic instability (182). In contrast, DNA
damage leads to the reduction of USP1 levels via transcriptional
and posttranslational mechanisms. It was shown that UV damage
causes the proteasomal degradation of USP1 (183). The degrada-
tion of USP1 is initiated through an autocleavage event, coupled
FIG 2 DUBs that regulate replication-associated repair (A), nucleotide excision repair (B), and alkylation adducts repair (C).?a indicates that both proteolytic
and nonproteolytic ubiquitination are reported. RNF111 induces K63-linked polyubiquitin chains on SUMO-modified XPC (not shown). RNF111 and CUL4-
DDB2 possibly have opposing roles in the chromatin recruitment of XPC but collaboratively regulate the timely recruitment and removal of XPC at the lesions.
As USP7 is not known to cleave K63 linkages, there may be more than one deubiquitinating enzymes involved.
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to recognition by the N-end rule pathway enzymes that subse-
quently target it for polyubiquitination and degradation (184).
How USP1 autocleavage is regulated in a signal-dependent man-
ner is still unknown.
In summary, USP1 negatively regulates several key ubiquitina-
tion processes in response to DNA damage. In addition to the
well-characterized ubiquitinated substrates described above,
USP1 was more recently shown to promote the stability of inhib-
itors of DNA binding (IDs) (family of transcriptional repressor
proteins) and rescue them from the UPS (185). The ID proteins
antagonize basic-helix-loop-helix (bHLH) transcription factors
to regulate differentiation and maintenance of stem cell fate. ID
proteins are known to inhibit the transcription of the cyclin kinase
(CDK) inhibitor, p21. p21 has a strong PIP box, and low levels of
p21 are sufficient to prevent TLS onset. Whether USP1 loss can
indirectly lead to upregulation of p21 transcriptional levels due to
the rapid turnover of IDproteins remains to be tested. Thus,USP1
may alter S-phase DNA repair events by targeting the deubiquiti-
nation ofmultiple substrates, including FANCI, FANCD2, PCNA,
and ID proteins. There are likely other substrates of USP1 that
directly regulate DNA repair and DNA replication kinetics during
S phase that have yet to be identified. While USP1 is the major
DUB that regulates TLS, USP7 has been implicated in the deubiq-
uitination of Rad18 and Pol eta to prevent their degradation via
the UPS (186, 187). Loss of USP7 destabilizes both Rad18 and Pol
eta proteins and compromisesUV-inducedPCNAmonoubiquiti-
nation and Pol eta recruitment to stalled replication forks, respec-
tively. As more ubiquitinated substrates are implicated in TLS,
there will likely be more DUBs involved in the regulation of the
DNA damage tolerance pathway.
Regulation of DUBs by oxidative stress. Bursts of reactive ox-
ygen species (ROS), such as H2O2, can be produced both by envi-
ronmental carcinogens and/or endogenous sources. While it was
once previously considered to be just a unwanted by-product of
aerobic respiration, accumulating evidence indicates that H2O2
also serves as a critical signaling molecule in cell proliferation and
survival (188). While there is a wealth of research demonstrating
the general adverse effect of oxidative stress on DNA damage and
cell death, much less is known about the signaling targets of ROS
that regulate cell growth andDNA repair in amore directmanner.
Protein tyrosine phosphatases (PTPs) are a family of redox-regu-
lated proteins that aremediators ofmultiple signaling pathways in
essential cellular processes such as proliferation, differentiation,
and migration (189). PTPs can be directly inactivated by ROS
through the oxidation of the catalytic Cys residue (190–192), and
this inactivation is typically transient and reversible under physi-
ological conditions. Thus, the reversibility of the reaction fine-
tunes the signaling pathways emanating from receptor tyrosine
kinases.
In a series of studies initiated by multiple groups, it was dem-
onstrated that members of the Cys protease family of DUBs, sim-
ilar to PTPs, were susceptible to redox regulation (193–195).
Strikingly, they found that these DUBs can be rapidly targeted by
ROSboth in vitro and in cells. USP1, aDUBcritical for both the FA
pathway and TLS (as mentioned above), is transiently oxidized
and inactivated in response to oxidative stress in cells, suggesting
that USP1 is responsible for fine-tuning the monoubiquitination
levels of PCNA during DNA lesion bypass (damage tolerance) for
oxidative DNA damage in replicating cells (193, 194, 196). USP7,
an important regulator of the nucleotide excision repair (NER)
and Mdm2-p53 tumor suppressor pathway (see below), can also
be reversibly oxidized and inactivated in cells (193). Using mass
spectrometry and X-ray crystallography, the catalytic Cys residue
was shown to be the target of oxidative modification (193, 195).
There are likelymany other redox-regulatedDUBs that play a role
in genome stability pathways. The molecular mechanisms that
govern DUB redox regulation and how dysregulation can impact
multiple DNA repair pathways and genomic instability in human
cells are still active areas of study.
Regulation of replication fork progression by BAP1. While
BAP1 was shown to be involved inHR repair as discussed above, a
more recent study showed that BAP1 is also required for DNA
replication fork progression by deubiquitinating and stabilizing
the INO80 ATPase subunit of the large INO80 complex, a chro-
matin remodeler that is involved in DNA replication and tran-
scription (197). BAP1 is visible at the PCNA-containing replica-
tion fork foci, and by associating with H2A-Ub, it recruits INO80
to the replication foci (197). Similar to the effect of INO80 deple-
tion, BAP1 depletion leads to impairment of replication fork pro-
gression, aneuploidy, chromosomal aberration, and developmen-
tal defects of mice (197). The role of BAP1 in DNA replication
progression is partly attributed to stabilizing INO80 at replication
forks, but there may be another unknown function of BAP1 in
supporting DNA replication and alleviating replication stress
(197). INO80 was also shown to be recruited to DSB sites through
interacting with H2A and H2AX in yeast, and it promotes DSB
end resection possibly by clearing out nucleosomes (154, 198,
199). Therefore, it is possible that BAP1 also affects DSB repair
efficiency by modulating INO80 stability at DSB sites. Indeed,
BAP1 is implicated in promoting DSB repair and conferring resis-
tance to DNA-damaging agents (117). However, the INO80-sta-
bilizing role of BAP1 may be specific only in the context of repli-
cation fork progression, as evidenced by S-phase-specific
costaining of BAP1 and INO80 at the PCNA-containing replica-
tion foci (197).
DUBs THAT REGULATE REMOVAL OF BULKY ADDUCTS ON
DNA
USP7 regulates nucleotide excision repair.USP7 (also known as
HAUSP [herpesvirus-associated ubiquitin-specific protease])
regulates cellular DNA damage response by modulating many
substrates includingMDM2andp53, but probably themost direct
role of USP7 in DNA repair is in regulating nucleotide excision
repair (NER). NER is a repair mechanism that removes various
types of bulky DNA adducts, such as UV-induced thymidine
dimers. Recognition of the bulky lesions leads to removal of the
short stretch of single-stranded DNA that contains the lesion,
while the undamaged strand remains intact and serves as a tem-
plate for DNA synthesis by DNA polymerases. Two distinct sub-
pathways exist for NER: global genomic NER (GG-NER), which
operates throughout the genome, and transcription-coupledNER
(TC-NER), which removes DNA adducts at the transcriptionally
active sites (200, 201). Amajor difference between these two path-
ways lies in the way damaged sites are recognized; GG-NER uti-
lizes DDB2 (forms a complex with DDB1) or XPC (forms a com-
plex with human RAD23 [hRAD23]) as the lesion recognition
factor, while TC-NER appears to be initiated by RNA polymerase
II stalling at the lesion. Genetic defects in TC-NER can lead to
disorders such as Cockayne syndrome (CS) andUV-sensitive syn-
drome (UVSS), whose common feature is increased UV sensitiv-
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ity. The current model suggests that stalled RNA polymerase II at
damaged sites triggers recruitment of TC-NER-specific factors
CSA (or ERCC8) and CSB (or ERCC6). CSB may rearrange the
nucleosome structure around the stalled Pol II, and together with
CSA, it facilitates recruitment of the TC-NER repair complex that
includes repair/transcription complex including TFIIH, XPA,
XPG, and ERCC-XPF1 nuclease (200–202). CSA and CSB play
essential roles in TC-NER by temporarily displacing (or allowing
backtracking) RNA Pol II from the damaged sites. Upon comple-
tion of repair, it is necessary to remove the TC-NER repair com-
plex, and polyubiquitination and degradation of CSB were sug-
gested to be one such post-TC-NER recovery mechanism (203)
(Fig. 2).Whether deubiquitination of CSB is an essential event for
the integrity of the TC-NER pathwaywas unknown. In theory, the
deubiquitination activity may preserve or enhance the CSB-me-
diated displacement of RNA Pol II at damaged sites during the
repair time frame. It was indeed shown thatUSP7 stabilizes CSB to
regulate the efficiency of the TC-NER pathway (204, 205). Re-
cruitment of USP7 to the damaged sites and to the RNA Pol II
complex ismediated by a scaffold proteinUVSSA (UV-stimulated
scaffold protein A), one of the three complementation groups
identified for UVSS patients (the other two groups being CSA and
CSB). The protein level of CSB is lower in patient-derivedUVSSA-
deficient cells, and consistently, knockdown of UVSSA or USP7
leads to accelerated degradation of CSB by the UPS, UV sensitiv-
ity, and reduced RNA synthesis recovery from UV (204–206).
Whether USP7 directly deubiquitinates CSB was not demon-
strated in biochemical assays; however, a model in which USP7
deubiquitinates and stabilizes CSB/ERCC6 to facilitate the com-
pletion of TC-NER repair has been suggested (207). Of note was
the observation that overexpressing CSB did not rescue the TC-
NER defect of UVSS cells, which suggested that there are other
mechanisms/substrates regulated by the UVSSA/USP7 complex
(204). The steady-state level of RNA Pol II was also slightly lower
in USP7 knockdown cells, suggesting that USP7 also deubiquiti-
nates and stabilizes RNA Pol II, although this has not been for-
mally tested (207).
USP7 may also regulate GG-NER by deubiquitinating XPC.
XPC, in complex with hRAD23, plays a key role in the GG-NER
pathway by inducing the formation of the preincision complex
and senses a broad spectrum of lesions. Regulating XPC loading
onto chromatin by polyubiquitination appears to be a key event in
the GG-NER. XPC is ubiquitinated by two E3 ubiquitin ligases,
CUL4-DDB2 (208) and RNF111 (209, 210). The CUL4-DDB2 E3
ligase polyubiquitinates XPC and does not lead to proteasomal
degradation but rather promotes increased binding affinity of
XPC to DNA (208). XPC is also ubiquitinated by RNF111, a
SUMO-targeted E3 ubiquitin ligase that induces polyubiquiti-
nation on presumoylated XPC. Ubiquitination is mediated by
UBC13/MMS2 E2-conjugating enzyme, suggesting that it is likely
a nonproteolytic K63-linked polyubiquitination event. Interest-
ingly, RNF111-mediated polyubiquitination induces the release
of XPC from the lesions (209, 210), which is the opposite effect of
CUL4-DDB2 mediated polyubiquitination. Both DDB2 and
RNF111 depletion impair the UV-induced DNA repair, suggest-
ing a model in which two sequential polyubiquitination events on
XPC regulate the recruitment and release of XPC during NER.
The RNF111-induced release of XPC from chromatin is required
for recruitment of downstream NER factors and completion of
repair (210). A recent study found that USP7 directly binds to and
deubiquitinates XPC and that UV-induced XPC degradation is
accelerated in USP7/ HCT116 cells (211). The USP7/ cells
are defective in repairing UV-induced photoadducts, confirming
thatUSP7’s role in deubiquitinating and stabilizingXPC is impor-
tant in NER. It is unclear whether USP7 serves to counteract
polyubiquitination induced by CUL4/DDB2 or RNF111, but this
seems unlikely as these ubiquitination mechanisms are nonpro-
teolytic. It is possible that there is a yet-to-be identified ubiquitin
E3 ligase-mediated polyubiquitination event that induces XPC
degradation, which may be a necessary step upon completion of
NER. It is also possible that an unknown DUB is responsible for
counteracting nonproteolytic ubiquitination of XPC that regu-
lates its chromatin loading at damage sites. Altogether, USP7
serves as an important regulator of both subpathways of NER by
regulating stability of CSB/ERCC6 and perhaps both stability and
chromatin loading of XPC, thus overall orchestrating UV-in-
duced NER repair and cell survival.
A study found thatUSP24 is also involved in the ubiquitination
events during the UV response. USP24 binds to, deubiquitinates,
and stabilizes the DDB2 component of CUL4 E3 ligase (212). As
CUL4-DDB2 is known to polyubiquitinate XPC, whether USP24
influences the XPC polyubiquitination or overall TC-NER is not
known, although USP24 depletion increases the UV sensitivity of
cells (213).
DUBs THAT REGULATE REMOVAL OF NONBULKY ADDUCTS
ON DNA
USP47 regulates base excision repair by stabilizing DNA poly-
merase beta. Base excision repair (BER) is an essential cellular
process required for genome stability. Loss of BER function has
been linked to premature aging, increased rate of mutagenesis,
and cancer (214, 215). BER is active throughout the cell cycle and
is critical for the removal of DNA lesions due to deamination,
oxidation, and alkylation. BER is initiated by DNA glycosylases,
which recognize and remove specific damaged or inappropriate
bases, forming abasic sites (AP sites). These sites are then cleaved
by an AP endonuclease, the resulting single-strand break (SSB)
can then be processed by either short-patch BER (where a single
nucleotide is replaced) or long-patch BER (where 2 to 10 nucleo-
tides are newly synthesized). The SSB is repaired by a DNA repair
complex that includes DNA polymerase beta (Pol), XRCC1, and
DNA ligase. Pol plays a central role in BERwith both an AP lyase
and DNA polymerase activity. The importance of Pol is high-
lighted by the fact that a knockout of the pol gene inmice results
in early embryonic lethality and hypersensitivity to DNA-damag-
ing agents (216, 217). Furthermore, the regulation of cellular Pol
levels is vital, since both under- and overproduction of Pol lead
to deficient repair or an increased rate of mutagenesis, respec-
tively, and both have been linked to increased cancer susceptibility
(218–220). Parsons and colleagues have previously shown that the
steady-state level of BER enzymes, including Pol, is tightly regu-
lated and directly linked to the amount of endogenous DNA le-
sions (221). For example, if the level of Pol exceeds the level of
DNA lesions, then the excess or newly synthesized Pol becomes
ubiquitinated and degraded by the UPS (Fig. 2). This is achieved
by sequential ubiquitination of Pol by the E3 ubiquitin ligases
Mule (ARF-BP1) and CHIP, whereby Mule first targets Pol for
monoubiquitination, which then seeds the protein for polyubiq-
uitination by CHIP and subsequent targeting to the proteasome
for degradation (222). The same group has also identified USP47
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as themajor DUB responsible for deubiquitinating Pol to rescue
it from proteasomal degradation (223). Consistent with this role,
loss of USP47 increased the level of ubiquitinated Pol, decreased
Pol levels, and caused a defect in BER. The defect in BER is
reflected by the accumulation of DNA strand breaks and de-
creased cell viability in response to DNA damage. The E3 ubiqui-
tin ligase Mule is also subjected to regulation via a phosphorylat-
ed-Ser18-containing isoform of USP7 (noted as USP7S). USP7S
controls the protein stability of Mule by preventing the ubiquitin
ligase from autoubiquitination and subsequent proteasomal deg-
radation (224). USP7S was previously shown to be stabilized by
CK2 protein kinase-dependent phosphorylation in unstressed
cells (225). Upon DNA damage, the protein phosphatase PPM1G
is activated by ATM, resulting in the dephosphorylation and sub-
sequent destabilization of USP7S. Thus, DNA damage-dependent
downregulation of USP7S leads to the reduction of Mule and
likely stabilization of BER proteins. Other BER enzymes, includ-
ing DNA glycosylases, have been implicated as targets of different
E3 ubiquitin ligases (226). The function of ubiquitination in some
of these substrates still needs to be worked out, and whether
USP47 or USP7S plays a role in their deubiquitination remains to
be determined.
TheOTUD4-USP7-USP9X complex regulates the reversal of
alkylated DNA. Alkylation of DNA is one of the most frequent
mutagenic events the cell encounters. DNA alkylation can occur
by endogenous alkylating agents (e.g., S-adenosylmethionine
[SAM]), as well as exogenous sources such as chloromethane or
MMS (methyl methanesulfonate) (227). Alkylating agents such as
MMS are mostly methylating agents. DNA alkylation can be re-
paired by at least three repair mechanisms: BER (base excision
repair), direct base repair by methyltransferases, or base repair by
oxidative demethylases. Much of the knowledge on alkylation re-
pair came from studies on AlkB, an oxidative demethylase from
Escherichia coli, which removes methyl groups from various sites
on bases. In humans, there are nine AlkB family members. Of
these family members, ALKBH2 (human ABH2 [hABH2]) and
ALKBH3 (hABH3) are considered two human functional ho-
mologs of the E. coli AlkB (228). Evidence suggests that ALKBH2
preferentially removesmethyl groups fromdouble-strandedDNA
and that ALKBH3 prefers single-stranded DNA or RNA as the
substrate (228). How this class of DNA repair enzymes is func-
tionally regulated has not been well studied. A recent study dem-
onstrated that the stability of both ALKBH2 and ALKHB3 is reg-
ulated by the UPS (229). OTUD4, a member of the OTU DUB
family with little known function, has been shown to interact with
and stabilize ALKBH3 and ALKBH2 (229). Intriguingly, overex-
pression of not only the wild type but also a catalytic mutant form
of OTUD4 can suppress ubiquitination and degradation of
ALKBH3, suggesting that it is not dependent on the deubiquiti-
nating activity of OTUD4. Characterization of ALKBH3-interact-
ing proteins revealed that two USP family DUBs, USP7 and
USP9x, are associated with OTUD4, and overexpression of these
USPs (wild type but not catalytic mutant) can suppress the ubiq-
uitination and degradation of ALKBH3 in the presence of
OTUD4. This led to a model that OTUD4 serves as a scaffolding
factor that recruits USP7 and USP9x to ALKBH3 for deubiquiti-
nation. Consistent with the role of ALKBH2 and ALKBH3, the
knockdown of OTUD4, USP7, or USP9x sensitizes cells to DNA-
alkylating agents, which is correlatedwith reducedALKBH3.Why
and how ALKBH2 and ALKBH3 are ubiquitinated and degraded
is unknown, but it is possible that these repair enzymes are kept at
low levels under normal conditions, and DNA alkylation events
may require rapid stabilization by the DUBs. Thus, there must be
amechanism to inhibit DUB activity upon recovery fromdamage.
Given the increasing evidence for the role of ALKBH2 and
ALKBH3 in cancer development and chemoresistance, more in-
formation on these DUBs will be necessary for developing effec-
tive therapeutic strategies (229). The processing of alkylation
products can lead to secondary lesions such as single- and double-
strand breaks, and OTUD4-USP7-USP9x may also be essential in
repairing more complicated DNA repair processes.
FUTURE PERSPECTIVES
Specific functions or functional redundancy? Despite greater
understanding of DUBs in DNA repair, key questions remain.
Why are different DUBs with seemingly redundant roles needed
to regulate certain DNA repair processes? Clearly, functional re-
dundancy provides a better safety net to ensure genome integrity.
To ensure tight regulation, each DUBmay function at temporally
distinct stages during DDR. For instance, different kinetics for Ub
conjugate and DDR mediator recruitment were seen upon
OTUB1 and OTUB2 depletion under the same experimental set-
tings (76). This suggested that OTUB2 may function in the early
phases of DDR (10 min), whereas OTUB2 functions at later
phases. It is also possible that different DUBs act sequentially to
cooperate together to remove polyubiquitin chains from target
substrates. For instance, POH1may act to cleave the first proximal
ubiquitin moiety on H2A/H2AX to release polyubiquitin chains
en bloc, which can then be followed by USP5 or other DUBs that
may disassemble the unanchored polyubiquitin chains. Perhaps
different DUBs acting on the same polyubiquitinated substrate
may be subjected to ubiquitin chain editing, leading to diverse
functions for the individually modified substrate. A recent study
demonstrated the functional relevance of branched ubiquitin
chains for cell cycle regulation (242). Whether the formation of
branched ubiquitin chains plays a role in the DNA repair pathway
remains to be formally tested, but the likelihood is high. Another
outstanding question is whether we have completely exhausted
the search for ubiquitinated substrates involved in DNA repair at
damaged sites (the polyubiquitin signal in DNA damage foci
marked by the FK2 antibody). Identifying and generating a com-
prehensive list of damage-inducible ubiquitinated substrates that
localize to damaged sites will enable researchers to determine
whether some of these substrates are true targets of these DUBs or
whether some of these DUBs are functionally redundant (Table
1). With the advent of quantitative mass spectrometry-based pro-
teomics (243), it may soon be easier to identify all the ubiquiti-
nated substrates for a specific DUB by coupling DUB inhibition
(using a chemical inhibitor, RNAi, or inducible knockout strat-
egy) to the enrichment of ubiquitin conjugates using Lys-ε-Gly-
Gly (diGly)-based proteomics.
Regulation of DUBs.How are different DUBs recruited to dif-
ferent types of DNA lesions? There are only a handful of DUBs
that have localization signals to specific compartments. Further-
more, DUBs typically do not contain modular substrate-binding
domains (akin to the F-box proteins for the SCF ubiquitin E3
ligase complex) that specifically recognize substrates for deubiq-
uitination. Thus, DUB activity must be recruited by its associated
factor(s) to specific substrates or cellular compartments for deu-
biquitination. The critical roles of DUB binding partners in dic-
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tating DUB subcellular localization are well demonstrated by
BRCC36 and its binding proteins CCDC98/Abraxas (part of the
BRCA1-A complex) and KIAA0157 (part of the BRISC complex).
Knockdown of CCDC98/Abraxas or overexpressing KIAA0157
increases the cytosolic pool of BRCC36, whereas knockdown of
KIAA0157 or overexpressing CCDC98 increases the nuclear pool
of BRCC36 (58, 230). The components of the BRCA1-A complex
are essential for the catalytic activity and stability of BRCC36 (230,
231). Thus, the activity and localization may be regulated at mul-
tiple levels to ensure the proper localization of the HR-limiting
BRCC36 activity. How a single DUB, such as USP7, can partici-
pate in different types of DNA repair processes remains to be
understood. USP7 is localized to UV-induced lesions by a scaf-
folding protein, UVSSA, which in turn associates with NER fac-
tors. A different pool of USP7 may be recruited to the OTUD4
scaffold to regulate repair of alkylated DNA or to associate with
RNF168 to regulate DSB repair. It is possible that the differential
recruitment of a DUB to different sites is regulated by distinct
damage response types. Conversely, a single cofactor can activate
different DUBs by simply binding to these DUBs, as shown by
UAF1 in forming three distinct DUB complexes (175, 232). It is
also intriguing to imagine how DUBs that are part of large com-
plexes are spatially coordinated at the sites of damage. BRCC36 is
part of a multisubunit BRCA1 complex, and POH1 is part of the
16-subunit 19S proteasome lid complex. The fact that the catalytic
activity and protein stability of BRCC36 and POH1 require their
binding subunits or partners suggests that the larger complexes
may be present at DSB sites to disassemble the ubiquitin chains. It
will be interesting to find out whether these larger complexes are
necessary to regulate substrate specificity and/or localization and
recruitment processes. Better understanding of the recruitment
modules may further elucidate the specific biological functions of
each DUB and perhaps explain the complexity of DUB toolkits in
DNA repair.
DUBs as therapeutic targets. As it has become clear that in-
hibiting selective DUBs impairs the ability to respond and repair
DNA lesions, DUBs are appreciated as attractive clinical targets in
order to suppress “DNA repair addictive” tumors (233, 234).
Given that the activity of these DUBs can be locally inhibited in
tumor cells, pharmacologic targeting of these DUBs could be use-
ful for sensitizing the cancer cells to chemotherapeutics in clinical
settings. However, without the complete understanding of the
molecular basis and biology of these targeted DUBs, it remains a
challenge to predict whether DUBsmake good therapeutic targets
for cancer and other human diseases.
Many DUBs exert pleiotropic functions by regulating multiple
factors that are not necessarily in the same pathway or even in the
same subcellular compartment. However, an upside of this could
be that the pleiotropic nature of DUBs may allow them to be
more-effective targets, as targeting a single DUB may sensitize
cancer cells to chemotherapy due to the pleiotropic functions of
theDUB in several DNA repair pathways. For instance, disrupting
USP7 causes toxicity to cancer cells by inducing p53-mediated
apoptosis (235), but the other roles of USP7 in multiple DSB re-
pair pathways (e.g., DSB repair signaling, NER, TLS, alkylation
repair) and in cell cycle checkpoints and transcriptional silencing
may potentiate the cell-killing effect further by allowing irrepara-
ble DNA lesions to cause mitotic catastrophe. Similarly, USP9x
inhibition cannot induce apoptosis only by destabilizing antiapo-
ptotic MCL1 (236), but the apoptotic effect can also be further
potentiated by combining with a DNA-alkylating agent based
upon its role in stabilizing ALKBH3 (229). As for many other
therapeutic approaches of targeting DNA repair pathways, poten-
tial complications arising with spontaneous tumor develop-
ment in the long run should be taken into consideration when
inhibiting DUBs in DNA repair; for example, USP3 and USP44
knockout mice were born healthy, but they ultimately develop
tumors (83, 87).
A selective USP1-UAF1 inhibitor called ML323 has been de-
veloped recently and has shown promise in inhibiting the FA
pathway and TLS to potentiate cisplatin cytotoxicity in non-small
cell lung cancer and osteosarcoma cells in in vitro studies (237).
The idea that targeting USP1 could be useful in overcoming resis-
tance to platinum-based anticancer drugsmay be a logical strategy
for introducing new types of drugs to deal with chemoresistance.
Importantly, USP1 knockout mice are resistant to tumorigenesis
and prone to cellular senescence (238), suggesting that USP1 in-
hibition in the long runmay be beneficial in treating certain types
of cancers. Further understanding of the DUB function and reg-
ulation in DNA repair should equip us with better logistics in
developing new strategies for treating various human diseases.
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ADDENDUM IN PROOF
Orthwein and colleagues (A. Orthwein et al., Nature 528:422–
426, 2015, http://dx.doi.org/10.1038/nature16142) recently re-
ported a cell cycle-regulated mechanism to prohibit HR in G1 by
controlling the interaction of BRCA1 with PALB2-BRCA2
through PALB2 ubiquitination that is counteracted by USP11.
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